GCL
SCPH

Glazer Capital LLC’s scPharmaceuticals SCPH Stock Holding History

Glazer Capital LLC’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,381,691
Closed -$7.83M – 398
2025
Q3 		$7.83M Buy
+1,381,691
New +$7.08M 0.26% 89

Glazer Capital LLC's SCPH Position: Q4 2025 in Review

Glazer Capital LLC sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 1,381,691 shares — an estimated $7.83M sold.

Glazer Capital LLC first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $7.83M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Glazer Capital LLC reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Glazer Capital LLC sold 1,381,691 scPharmaceuticals shares in Q4 2025, an estimated $7.83M.
  • Glazer Capital LLC first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Glazer Capital LLC's scPharmaceuticals position peaked at $7.83M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.